Missed treatments and waiting lists: "In Sardinia, one out of three specialist visits is missed"According to Salutequità, the medical services of the NHS are still below the average of the pre-Covid period: "The care for the chronically ill suffers above all, which in 2022 on the island recorded almost -37% compared to 2019"
In Sardinia, one specialist visit out of three "skips" due to waiting lists and the many problems afflicting the national health system.
A negative primacy that the island shares with Valle d'Aosta, Calabria and Molise, according to what is reported by an analysis, carried out by Salutequità , entitled "Missed cures and PDTA for chronicity".
The dossier highlights how, «despite the progressive improvement in the management of Covid-19 by the National Health Service and the stationing from 2020 of around one billion euros for the recovery of waiting lists, the current capacity of the National Health System to guaranteeing citizens access to health services is still lower than the pre-pandemic period (2019) and with unacceptable differences between the Regions ».
"The loser - underlines Salutequità - are also the treatments for the chronically ill ", which in 2022 in Sardinia recorded almost -37% compared to 2019 .
"The recovery and management of waiting lists represent a priority for citizens and the National Health Service, on which all the Regions must continue to work very carefully", comments Tonino Aceti, president of Salutequità .
«Even the adherence to pharmacological treatment for people suffering from chronic conditions - the report also highlights - has undergone variations in the pandemic period. The level of high adherence is highly differentiated between patients suffering from various chronic pathologies: it is higher in people with hypertension, heart failure (they have high adherence over 50%, 1 in 2 people) and progressively decreases among people with asthma and COPD (high adherence for less than 1 in 4 people) and those with diabetes (high adherence for less than 1 in 3 patients with diabetes).
«The pandemic - concludes the association - has also increased the number of people with low adherence to drugs for heart failure and hypertension in adults over 45 and in 2021 the distances with the 2019 levels have still not been recovered: we have gone from 17.7 to 18% in 2021. The number of low-adherents is especially present in the south 19.3% and among women (20.8% compared to 14.8 low-adherent men). In 2021, 0.1% of low adherents were recovered compared to 2020 (where the loss was 0.4%).